▶ 調査レポート

悪性神経膠腫治療の世界市場:市場規模・現状・予測

• 英文タイトル:Global Malignant Glioma Therapeutic Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。悪性神経膠腫治療の世界市場:市場規模・現状・予測 / Global Malignant Glioma Therapeutic Market Size, Status and Forecast 2019-2025 / QYR9ST04195資料のイメージです。• レポートコード:QYR9ST04195
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、91ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、悪性神経膠腫治療の世界市場について調査・分析し、悪性神経膠腫治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(化学療法、医薬品)、用途別(病院、癌研究機関、診断センター、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の悪性神経膠腫治療市場動向
・主要企業別マーケットシェア
・悪性神経膠腫治療の種類別市場規模2014-2019
(化学療法、医薬品)
・悪性神経膠腫治療の用途別市場規模2014-2019
(病院、癌研究機関、診断センター、その他)
・悪性神経膠腫治療の北米市場:主要企業・種類別/用途別市場規模
・悪性神経膠腫治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・悪性神経膠腫治療の中国市場:主要企業・種類別/用途別市場規模
・悪性神経膠腫治療の日本国内市場:主要企業・種類別/用途別市場規模
・悪性神経膠腫治療の東南アジア市場:主要企業・種類別/用途別市場規模
・悪性神経膠腫治療のインド市場:主要企業・種類別/用途別市場規模
・悪性神経膠腫治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Merck、Eli Lilly、AbbVie、Bristol-Myers Squibb、Genentech、Sun Pharmaceutical、BioMimetix、Cipla、Sigma-Aldrich、Panacea Biotec、Zydus Cadila)
・悪性神経膠腫治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Malignant glioma’s are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers.In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and prevalence cases, followed by Europe where the major pharmaceuticals have their blockbuster drugs and include the major funding associations.
In 2018, the global Malignant Glioma Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Malignant Glioma Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Malignant Glioma Therapeutic development in United States, Europe and China.

The key players covered in this study
Merck
Eli Lilly
AbbVie
Bristol-Myers Squibb
Genentech
Sun Pharmaceutical
BioMimetix
Cipla
Sigma-Aldrich
Panacea Biotec
Zydus Cadila

Market segment by Type, the product can be split into
Chemotherapy
Drugs

Market segment by Application, split into
Hospitals
Cancer Research Organizations
Diagnostic Centers
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Malignant Glioma Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the Malignant Glioma Therapeutic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Malignant Glioma Therapeutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Malignant Glioma Therapeutic Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Drugs
1.5 Market by Application
1.5.1 Global Malignant Glioma Therapeutic Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Cancer Research Organizations
1.5.4 Diagnostic Centers
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Malignant Glioma Therapeutic Market Size
2.2 Malignant Glioma Therapeutic Growth Trends by Regions
2.2.1 Malignant Glioma Therapeutic Market Size by Regions (2014-2025)
2.2.2 Malignant Glioma Therapeutic Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Malignant Glioma Therapeutic Market Size by Manufacturers
3.1.1 Global Malignant Glioma Therapeutic Revenue by Manufacturers (2014-2019)
3.1.2 Global Malignant Glioma Therapeutic Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Malignant Glioma Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2 Malignant Glioma Therapeutic Key Players Head office and Area Served
3.3 Key Players Malignant Glioma Therapeutic Product/Solution/Service
3.4 Date of Enter into Malignant Glioma Therapeutic Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Malignant Glioma Therapeutic Market Size by Type (2014-2019)
4.2 Global Malignant Glioma Therapeutic Market Size by Application (2014-2019)

5 United States
5.1 United States Malignant Glioma Therapeutic Market Size (2014-2019)
5.2 Malignant Glioma Therapeutic Key Players in United States
5.3 United States Malignant Glioma Therapeutic Market Size by Type
5.4 United States Malignant Glioma Therapeutic Market Size by Application

6 Europe
6.1 Europe Malignant Glioma Therapeutic Market Size (2014-2019)
6.2 Malignant Glioma Therapeutic Key Players in Europe
6.3 Europe Malignant Glioma Therapeutic Market Size by Type
6.4 Europe Malignant Glioma Therapeutic Market Size by Application

7 China
7.1 China Malignant Glioma Therapeutic Market Size (2014-2019)
7.2 Malignant Glioma Therapeutic Key Players in China
7.3 China Malignant Glioma Therapeutic Market Size by Type
7.4 China Malignant Glioma Therapeutic Market Size by Application

8 Japan
8.1 Japan Malignant Glioma Therapeutic Market Size (2014-2019)
8.2 Malignant Glioma Therapeutic Key Players in Japan
8.3 Japan Malignant Glioma Therapeutic Market Size by Type
8.4 Japan Malignant Glioma Therapeutic Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Malignant Glioma Therapeutic Market Size (2014-2019)
9.2 Malignant Glioma Therapeutic Key Players in Southeast Asia
9.3 Southeast Asia Malignant Glioma Therapeutic Market Size by Type
9.4 Southeast Asia Malignant Glioma Therapeutic Market Size by Application

10 India
10.1 India Malignant Glioma Therapeutic Market Size (2014-2019)
10.2 Malignant Glioma Therapeutic Key Players in India
10.3 India Malignant Glioma Therapeutic Market Size by Type
10.4 India Malignant Glioma Therapeutic Market Size by Application

11 Central & South America
11.1 Central & South America Malignant Glioma Therapeutic Market Size (2014-2019)
11.2 Malignant Glioma Therapeutic Key Players in Central & South America
11.3 Central & South America Malignant Glioma Therapeutic Market Size by Type
11.4 Central & South America Malignant Glioma Therapeutic Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Malignant Glioma Therapeutic Introduction
12.1.4 Merck Revenue in Malignant Glioma Therapeutic Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Malignant Glioma Therapeutic Introduction
12.2.4 Eli Lilly Revenue in Malignant Glioma Therapeutic Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 AbbVie
12.3.1 AbbVie Company Details
12.3.2 Company Description and Business Overview
12.3.3 Malignant Glioma Therapeutic Introduction
12.3.4 AbbVie Revenue in Malignant Glioma Therapeutic Business (2014-2019)
12.3.5 AbbVie Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 Malignant Glioma Therapeutic Introduction
12.4.4 Bristol-Myers Squibb Revenue in Malignant Glioma Therapeutic Business (2014-2019)
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Genentech
12.5.1 Genentech Company Details
12.5.2 Company Description and Business Overview
12.5.3 Malignant Glioma Therapeutic Introduction
12.5.4 Genentech Revenue in Malignant Glioma Therapeutic Business (2014-2019)
12.5.5 Genentech Recent Development
12.6 Sun Pharmaceutical
12.6.1 Sun Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Malignant Glioma Therapeutic Introduction
12.6.4 Sun Pharmaceutical Revenue in Malignant Glioma Therapeutic Business (2014-2019)
12.6.5 Sun Pharmaceutical Recent Development
12.7 BioMimetix
12.7.1 BioMimetix Company Details
12.7.2 Company Description and Business Overview
12.7.3 Malignant Glioma Therapeutic Introduction
12.7.4 BioMimetix Revenue in Malignant Glioma Therapeutic Business (2014-2019)
12.7.5 BioMimetix Recent Development
12.8 Cipla
12.8.1 Cipla Company Details
12.8.2 Company Description and Business Overview
12.8.3 Malignant Glioma Therapeutic Introduction
12.8.4 Cipla Revenue in Malignant Glioma Therapeutic Business (2014-2019)
12.8.5 Cipla Recent Development
12.9 Sigma-Aldrich
12.9.1 Sigma-Aldrich Company Details
12.9.2 Company Description and Business Overview
12.9.3 Malignant Glioma Therapeutic Introduction
12.9.4 Sigma-Aldrich Revenue in Malignant Glioma Therapeutic Business (2014-2019)
12.9.5 Sigma-Aldrich Recent Development
12.10 Panacea Biotec
12.10.1 Panacea Biotec Company Details
12.10.2 Company Description and Business Overview
12.10.3 Malignant Glioma Therapeutic Introduction
12.10.4 Panacea Biotec Revenue in Malignant Glioma Therapeutic Business (2014-2019)
12.10.5 Panacea Biotec Recent Development
12.11 Zydus Cadila

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Malignant Glioma Therapeutic Key Market Segments
Table Key Players Malignant Glioma Therapeutic Covered
Table Global Malignant Glioma Therapeutic Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Malignant Glioma Therapeutic Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Drugs Figures
Table Key Players of Drugs
Table Global Malignant Glioma Therapeutic Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Cancer Research Organizations Case Studies
Figure Diagnostic Centers Case Studies
Figure Other Case Studies
Figure Malignant Glioma Therapeutic Report Years Considered
Table Global Malignant Glioma Therapeutic Market Size 2014-2025 (Million US$)
Figure Global Malignant Glioma Therapeutic Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Malignant Glioma Therapeutic Market Size by Regions 2014-2025 (Million US$)
Table Global Malignant Glioma Therapeutic Market Size by Regions 2014-2019 (Million US$)
Table Global Malignant Glioma Therapeutic Market Share by Regions 2014-2019
Figure Global Malignant Glioma Therapeutic Market Share by Regions 2014-2019
Figure Global Malignant Glioma Therapeutic Market Share by Regions 2019
Table Market Top Trends
Table Global Malignant Glioma Therapeutic Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Malignant Glioma Therapeutic Market Share by Manufacturers (2014-2019)
Figure Global Malignant Glioma Therapeutic Market Share by Manufacturers in 2018
Table Global Malignant Glioma Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Malignant Glioma Therapeutic Product/Solution/Service
Table Date of Enter into Malignant Glioma Therapeutic Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Malignant Glioma Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Global Malignant Glioma Therapeutic Market Size Share by Type (2014-2019)
Figure Global Malignant Glioma Therapeutic Market Size Market Share by Type (2014-2019)
Table Global Malignant Glioma Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Global Malignant Glioma Therapeutic Market Size Share by Application (2014-2019)
Figure Global Malignant Glioma Therapeutic Market Size Market Share by Application (2014-2019)
Figure Global Malignant Glioma Therapeutic Revenue Market Share by Application in 2018
Figure United States Malignant Glioma Therapeutic Market Size 2014-2019 (Million US$)
Table United States Key Players Malignant Glioma Therapeutic Revenue (2018-2019) (Million US$)
Table United States Key Players Malignant Glioma Therapeutic Market Share (2018-2019)
Table United States Malignant Glioma Therapeutic Market Size by Type (2014-2019) (Million US$)
Table United States Malignant Glioma Therapeutic Market Share by Type (2014-2019)
Table United States Malignant Glioma Therapeutic Market Size by Application (2014-2019) (Million US$)
Table United States Malignant Glioma Therapeutic Market Share by Application (2014-2019)
Figure Europe Malignant Glioma Therapeutic Market Size 2014-2019 (Million US$)
Table Europe Key Players Malignant Glioma Therapeutic Revenue (2018-2019) (Million US$)
Table Europe Key Players Malignant Glioma Therapeutic Market Share (2018-2019)
Table Europe Malignant Glioma Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Europe Malignant Glioma Therapeutic Market Share by Type (2014-2019)
Table Europe Malignant Glioma Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Europe Malignant Glioma Therapeutic Market Share by Application (2014-2019)
Figure China Malignant Glioma Therapeutic Market Size 2014-2019 (Million US$)
Table China Key Players Malignant Glioma Therapeutic Revenue (2018-2019) (Million US$)
Table China Key Players Malignant Glioma Therapeutic Market Share (2018-2019)
Table China Malignant Glioma Therapeutic Market Size by Type (2014-20189) (Million US$)
Table China Malignant Glioma Therapeutic Market Share by Type (2014-2019)
Table China Malignant Glioma Therapeutic Market Size by Application (2014-2019) (Million US$)
Table China Malignant Glioma Therapeutic Market Share by Application (2014-2019)
Figure Japan Malignant Glioma Therapeutic Market Size 2014-2019 (Million US$)
Table Japan Key Players Malignant Glioma Therapeutic Revenue (2018-2019) (Million US$)
Table Japan Key Players Malignant Glioma Therapeutic Market Share (2018-2019)
Table Japan Malignant Glioma Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Japan Malignant Glioma Therapeutic Market Share by Type (2014-2019)
Table Japan Malignant Glioma Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Japan Malignant Glioma Therapeutic Market Share by Application (2014-2019)
Figure Southeast Asia Malignant Glioma Therapeutic Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Malignant Glioma Therapeutic Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Malignant Glioma Therapeutic Market Share (2018-2019)
Table Southeast Asia Malignant Glioma Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Malignant Glioma Therapeutic Market Share by Type (2014-2019)
Table Southeast Asia Malignant Glioma Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Malignant Glioma Therapeutic Market Share by Application (2014-2019)
Figure India Malignant Glioma Therapeutic Market Size 2014-2019 (Million US$)
Table India Key Players Malignant Glioma Therapeutic Revenue (2018-2019) (Million US$)
Table India Key Players Malignant Glioma Therapeutic Market Share (2018-2019)
Table India Malignant Glioma Therapeutic Market Size by Type (2014-2019) (Million US$)
Table India Malignant Glioma Therapeutic Market Share by Type (2014-2019)
Table India Malignant Glioma Therapeutic Market Size by Application (2014-2019) (Million US$)
Table India Malignant Glioma Therapeutic Market Share by Application (2014-2019)
Figure Central & South America Malignant Glioma Therapeutic Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Malignant Glioma Therapeutic Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Malignant Glioma Therapeutic Market Share (2018-2019)
Table Central & South America Malignant Glioma Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Central & South America Malignant Glioma Therapeutic Market Share by Type (2014-2019)
Table Central & South America Malignant Glioma Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Central & South America Malignant Glioma Therapeutic Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Malignant Glioma Therapeutic Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Malignant Glioma Therapeutic Business (2014-2019)
Table Merck Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Malignant Glioma Therapeutic Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Malignant Glioma Therapeutic Business (2014-2019)
Table Eli Lilly Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Malignant Glioma Therapeutic Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Malignant Glioma Therapeutic Business (2014-2019)
Table AbbVie Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Malignant Glioma Therapeutic Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Malignant Glioma Therapeutic Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Genentech Company Details
Table Genentech Revenue in Malignant Glioma Therapeutic Business (2014-2019)(Million US$)
Figure Genentech Revenue Growth Rate in Malignant Glioma Therapeutic Business (2014-2019)
Table Genentech Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Revenue in Malignant Glioma Therapeutic Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Revenue Growth Rate in Malignant Glioma Therapeutic Business (2014-2019)
Table Sun Pharmaceutical Recent Development
Table BioMimetix Company Details
Table BioMimetix Revenue in Malignant Glioma Therapeutic Business (2014-2019)(Million US$)
Figure BioMimetix Revenue Growth Rate in Malignant Glioma Therapeutic Business (2014-2019)
Table BioMimetix Recent Development
Table Cipla Company Details
Table Cipla Revenue in Malignant Glioma Therapeutic Business (2014-2019)(Million US$)
Figure Cipla Revenue Growth Rate in Malignant Glioma Therapeutic Business (2014-2019)
Table Cipla Recent Development
Table Sigma-Aldrich Company Details
Table Sigma-Aldrich Revenue in Malignant Glioma Therapeutic Business (2014-2019)(Million US$)
Figure Sigma-Aldrich Revenue Growth Rate in Malignant Glioma Therapeutic Business (2014-2019)
Table Sigma-Aldrich Recent Development
Table Panacea Biotec Company Details
Table Panacea Biotec Revenue in Malignant Glioma Therapeutic Business (2014-2019)(Million US$)
Figure Panacea Biotec Revenue Growth Rate in Malignant Glioma Therapeutic Business (2014-2019)
Table Panacea Biotec Recent Development
Table Zydus Cadila Company Details
Table Global Malignant Glioma Therapeutic Market Size by Regions (Million US$) 2019-2025
Figure Global Malignant Glioma Therapeutic Market Size Share by Regions (2019-2025)
Figure Global Malignant Glioma Therapeutic Market Size Share by Regions in 2025
Figure United States Malignant Glioma Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Europe Malignant Glioma Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure China Malignant Glioma Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Japan Malignant Glioma Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Malignant Glioma Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure India Malignant Glioma Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Malignant Glioma Therapeutic Market Size Forecast (2019-2025)(Million USD)
Table Global Malignant Glioma Therapeutic Market Size by Product (2019-2025) (Million US$)
Figure Global Malignant Glioma Therapeutic Market Size by Product (2019-2025)
Figure Global Malignant Glioma Therapeutic Market Size by Product in 2025
Table Global Malignant Glioma Therapeutic Market Size by Application (2019-2025) (Million US$)
Figure Global Malignant Glioma Therapeutic Market Size by Application (2019-2025)
Figure Global Malignant Glioma Therapeutic Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources